These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31816154)

  • 1. Impact of pre-existing hypertension and control status before atrial fibrillation onset on cardiovascular prognosis in patients with non-valvular atrial fibrillation: A real-world database analysis in Japan.
    Kario K; Abe T; Kanegae H
    J Clin Hypertens (Greenwich); 2020 Mar; 22(3):431-437. PubMed ID: 31816154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Causes of Ischemic Stroke in Patients with Non-Valvular Atrial Fibrillation.
    Nakamura A; Kuroda J; Ago T; Hata J; Matsuo R; Arakawa S; Kuwashiro T; Yasaka M; Okada Y; Kitazono T; Kamouchi M;
    Cerebrovasc Dis; 2016; 42(3-4):196-204. PubMed ID: 27111222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nonvalvular atrial fibrillation: data from the Observatory of Cardiovascular Diseases in the province of Trieste (Italy)].
    Mazzone C; Carriere C; Grande E; Iorio AM; Barbati G; Zecchin M; Serdoz LV; Cioffi G; Tarantini L; Sinagra G; Scardi S; Di Lenarda A
    G Ital Cardiol (Rome); 2015 Jun; 16(6):361-72. PubMed ID: 26156697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective observational study in elderly patients with non-valvular atrial fibrillation: Rationale and design of the All Nippon AF In the Elderly (ANAFIE) Registry.
    Inoue H; Yamashita T; Akao M; Atarashi H; Ikeda T; Okumura K; Koretsune Y; Shimizu W; Tsutsui H; Toyoda K; Hirayama A; Yasaka M; Yamaguchi T; Akishita M; Hasebe N; Kario K; Mizokami Y; Nagata K; Nakamura M; Terauchi Y; Yamamoto T; Teramukai S; Kimura T; Kaburagi J; Takita A
    J Cardiol; 2018 Oct; 72(4):300-306. PubMed ID: 29625717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern of atrial fibrillation and risk of outcomes: the Loire Valley Atrial Fibrillation Project.
    Banerjee A; Taillandier S; Olesen JB; Lane DA; Lallemand B; Lip GY; Fauchier L
    Int J Cardiol; 2013 Sep; 167(6):2682-7. PubMed ID: 22795403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factor profiles of stroke, myocardial infarction, and atrial fibrillation: a Japanese Multicenter Cooperative Registry.
    Uchiyama S; Shibata Y; Hirabayashi T; Mihara B; Hamashige N; Kitagawa K; Goto S; Origasa H; Shimada K; Kobayashi H; Isozaki M; Ikeda Y;
    J Stroke Cerebrovasc Dis; 2010 May; 19(3):190-197. PubMed ID: 20434045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial Fibrillation-Associated Ischemic Stroke Patients With Prior Anticoagulation Have Higher Risk for Recurrent Stroke.
    Tanaka K; Koga M; Lee KJ; Kim BJ; Park EL; Lee J; Mizoguchi T; Yoshimura S; Cha JK; Lee BC; Nakahara J; Suzuki N; Bae HJ; Toyoda K;
    Stroke; 2020 Apr; 51(4):1150-1157. PubMed ID: 32098607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and heart failure.
    Martinez BK; Bunz TJ; Eriksson D; Meinecke AK; Sood NA; Coleman CI
    ESC Heart Fail; 2019 Feb; 6(1):10-15. PubMed ID: 30299591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between Pre-Admission Risk Scores and Two-Year Clinical Outcomes in Ischemic Stroke or Transient Ischemic Attack Patients with Non-Valvular Atrial Fibrillation.
    Tokunaga K; Yamagami H; Koga M; Todo K; Kimura K; Itabashi R; Terasaki T; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Kameda T; Nagakane Y; Hasegawa Y; Shibuya S; Ito Y; Matsuoka H; Takamatsu K; Nishiyama K; Kario K; Yagita Y; Kitazono T; Kinoshita N; Takasugi J; Okata T; Yoshimura S; Sato S; Arihiro S; Toyoda K;
    Cerebrovasc Dis; 2018; 45(3-4):170-179. PubMed ID: 29597211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stroke Risk Status, Anticoagulation Treatment, and Quality-of-Life in Chinese Patients with Atrial Fibrillation: China Registry of Atrial Fibrillation (CRAF).
    Sun Y; Zhu J; Ma C; Liu S; Yang Y; Hu D
    Cardiovasc Ther; 2019; 2019():7372129. PubMed ID: 31772614
    [No Abstract]   [Full Text] [Related]  

  • 11. Real world adherence to oral anticoagulant in non-valvular atrial fibrillation patients in China.
    Xiang X; Cao Y; Sun K; Song J; Tian Y; Yin Q; Juan J; Hu Y
    Curr Med Res Opin; 2018 Feb; 34(2):255-261. PubMed ID: 29022745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of Hypertension and Systolic Blood Pressure With the Risk of Stroke or Bleeding in Patients With Atrial Fibrillation: The Fushimi AF Registry.
    Ishii M; Ogawa H; Unoki T; An Y; Iguchi M; Masunaga N; Esato M; Chun YH; Tsuji H; Wada H; Hasegawa K; Abe M; Akao M
    Am J Hypertens; 2017 Nov; 30(11):1073-1082. PubMed ID: 28575205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in Prevalence of Non-Valvular Atrial Fibrillation and Anticoagulation Therapy in a Japanese Region　- Analysis Using the National Health Insurance Database.
    Narita N; Okumura K; Kinjo T; Mikami J; Tsushima K; Takahashi R; Noro M; Hashimoto A; Sasaki T; Takaki M; Ishidoya E; Narita Y; Imai H; Ono E; Tomita H
    Circ J; 2020 Apr; 84(5):706-713. PubMed ID: 32213724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of gender on the prognosis of patients with nonvalvular atrial fibrillation.
    Inoue H; Atarashi H; Okumura K; Yamashita T; Origasa H; Kumagai N; Sakurai M; Kawamura Y; Kubota I; Matsumoto K; Kaneko Y; Ogawa S; Aizawa Y; Chinushi M; Kodama I; Watanabe E; Koretsune Y; Okuyama Y; Shimizu A; Igawa O; Bando S; Fukatani M; Saikawa T; Chishaki A;
    Am J Cardiol; 2014 Mar; 113(6):957-62. PubMed ID: 24461771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial fibrillation is associated with cardiovascular events in obese Japanese with one or more cardiovascular risk factors: The Japan Morning Surge Home Blood Pressure (J-HOP) Study.
    Watanabe H; Kabutoya T; Hoshide S; Kario K
    J Clin Hypertens (Greenwich); 2021 Mar; 23(3):665-671. PubMed ID: 33405296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effectiveness and safety of warfarin and dabigatran in patients with non-valvular atrial fibrillation in Japan: A claims database analysis.
    Koretsune Y; Yamashita T; Yasaka M; Ono Y; Hirakawa T; Ishida K; Kuroki D; Sumida T; Urushihara H
    J Cardiol; 2019 Mar; 73(3):204-209. PubMed ID: 30477926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of CHA
    Cheng X; Liu L; Li L; Zhao H; Li J; Shi J; Zhang W
    Intern Emerg Med; 2021 Aug; 16(5):1155-1163. PubMed ID: 33386603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-world persistence with direct oral anticoagulants (DOACs) in naïve patients with non-valvular atrial fibrillation.
    Ferroni E; Gennaro N; Costa G; Fedeli U; Denas G; Pengo V; Corti MC
    Int J Cardiol; 2019 Aug; 288():72-75. PubMed ID: 31043323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and Associated Stroke Risk of Human Immunodeficiency Virus-Infected Patients With Atrial Fibrillation　- A Nationwide Cohort Study.
    Jung H; Yang PS; Jang E; Yu HT; Kim TH; Uhm JS; Kim JY; Sung JH; Pak HN; Lee MH; Lip GYH; Joung B
    Circ J; 2019 Nov; 83(12):2547-2554. PubMed ID: 31619594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and effectiveness of non-vitamin K oral anticoagulants versus warfarin in real-world patients with non-valvular atrial fibrillation: a retrospective analysis of contemporary Japanese administrative claims data.
    Kohsaka S; Katada J; Saito K; Jenkins A; Li B; Mardekian J; Terayama Y
    Open Heart; 2020; 7(1):e001232. PubMed ID: 32341789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.